| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Papers In Press, published online ahead of print October 18, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Endocrine Research Unit, Mayo Clinic, Rochester, MN 55905
Corresponding Author: jensen.michael{at}mayo.edu
There has been more interest in Very-Low-Density-Lipoprotein (VLDL) triglyceride (TG) kinetics during the last decade. Unfortunately, robust measurement methods are elaborate and not readily available. Herein we describe a method utilizing unique, ex-vivo, labeling of fatty acid moiety of VLDL-TG followed by intravenous bolus infusion in the same person. We found that plasma disappearance of ex-vivo labeled VLDL-TG was comparable to in-vivo labeled VLDL-TG and that turnover rates can be safely estimated from log linear decay of VLDL-TG specific activity. We found minor labeling of plasma free fatty acid (FFA) (oleate) pool, which was largely attributed to co-infusion of free [14C]triolein; VLDL-TG did not contribute substantially to plasma FFA pool. The plasma decay curve of VLDL-TG was not affected by the presence of tracer in the FFA pool provided that the data from 2 hours after the VLDL tracer bolus infusion was used. The FFA contamination problem was circumvented by minor modification of the VLDL-TG tracer preparation. The approach we describe should expand the opportunity to study processes that cannot be assessed if the FFA precursor pool is labeled. This method for VLDL-TG tracer preparation can allow measurement of VLDL turnover, tissue uptake of VLDL-TG, and oxidation of VLDL-TG.
Revised on October 11, 2005
Accepted on October 17, 2005
Measuring VLDL-triglycerides turnover in humans using ex-vivo prepared VLDL tracer
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  R. H. Nelson, R. Basu, C. M. Johnson, R. A. Rizza, and J. M. Miles Splanchnic Spillover of Extracellular Lipase Generated Fatty Acids in Overweight and Obese Humans Diabetes, December 1, 2007; 56(12): 2878 - 2884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Nelson, D. S. Edgerton, R. Basu, J. C. Roesner, A. D. Cherrington, and J. M. Miles Triglyceride Uptake and Lipoprotein Lipase-Generated Fatty Acid Spillover in the Splanchnic Bed of Dogs Diabetes, July 1, 2007; 56(7): 1850 - 1855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Krag, L. C. Gormsen, Z. Guo, J. S. Christiansen, M. D. Jensen, S. Nielsen, and J. O. L. Jorgensen Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E920 - E927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Nelson, A. Prasad, A. Lerman, and J. M. Miles Myocardial Uptake of Circulating Triglycerides in Nondiabetic Patients With Heart Disease Diabetes, February 1, 2007; 56(2): 527 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Gormsen, M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen Energy expenditure, insulin, and VLDL-triglyceride production in humans J. Lipid Res., October 1, 2006; 47(10): 2325 - 2332. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
